Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19.
Codina H, Vieitez I, Gutierrez-Valencia A, Skouridou V, Martínez C, Patiño L, Botero-Gallego M, Trujillo-Rodríguez M, Serna-Gallego A, Muñoz-Muela E, Bobillo MM, Pérez A, Cabrera-Alvar JJ, Crespo M, O'Sullivan CK, Ruiz-Mateos E, Poveda E. Codina H, et al. Microorganisms. 2021 Oct 29;9(11):2259. doi: 10.3390/microorganisms9112259. Microorganisms. 2021. PMID: 34835384 Free PMC article.
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
Milanés-Guisado Y, Gutiérrez-Valencia A, Muñoz-Pichardo JM, Rivero A, Trujillo-Rodriguez M, Ruiz-Mateos E, Espinosa N, Roca-Oporto C, Viciana P, López-Cortés LF. Milanés-Guisado Y, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):200-207. doi: 10.1093/jac/dkz421. J Antimicrob Chemother. 2020. PMID: 31617904
Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus.
De Pablo-Bernal RS, Jimenez-Leon MR, Tarancon-Diez L, Gutierrez-Valencia A, Serna-Gallego A, Trujillo-Rodriguez M, Alvarez-Rios AI, Milanes-Guisado Y, Espinosa N, Roca-Oporto C, Viciana P, Lopez-Cortes LF, Ruiz-Mateos E. De Pablo-Bernal RS, et al. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00773-20. doi: 10.1128/AAC.00773-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32571815 Free PMC article.
Antiretroviral Treatment for HIV Elite Controllers?
Ruiz-Mateos E, Poveda E, Lederman MM. Ruiz-Mateos E, et al. Pathog Immun. 2020 May 19;5(1):121-133. doi: 10.20411/pai.v5i1.364. eCollection 2020. Pathog Immun. 2020. PMID: 32582872 Free PMC article.
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.
Poveda E, Tabernilla A, Fitzgerald W, Salgado-Barreira Á, Grandal M, Pérez A, Mariño A, Álvarez H, Valcarce N, González-García J, Bernardino JI, Gutierrez F, Fujioka H, Crespo M, Ruiz-Mateos E, Margolis L, Lederman MM, Freeman ML. Poveda E, et al. J Infect Dis. 2022 Mar 15;225(6):1040-1049. doi: 10.1093/infdis/jiaa375. J Infect Dis. 2022. PMID: 32603406 Free PMC article.
Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: Early results of a phase I/II clinical trial.
Trujillo-Rodríguez M, Viciana P, Rivas-Jeremías I, Álvarez-Ríos AI, Ruiz-García A, Espinosa-Ibáñez O, Arias-Santiago S, Martínez-Atienza J, Mata R, Fernández-López O, Ruiz-Mateos E, Gutiérrez-Valencia A, López-Cortés LF. Trujillo-Rodríguez M, et al. Stem Cells Transl Med. 2021 Apr;10(4):534-541. doi: 10.1002/sctm.20-0213. Epub 2020 Dec 2. Stem Cells Transl Med. 2021. PMID: 33264515 Free PMC article. Clinical Trial.
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection.
Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Pérez-Gómez A, et al. Cell Mol Immunol. 2021 Sep;18(9):2128-2139. doi: 10.1038/s41423-021-00728-2. Epub 2021 Jul 21. Cell Mol Immunol. 2021. PMID: 34290398 Free PMC article.
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression.
Álvarez H, Ruiz-Mateos E, Juiz-González PM, Vitallé J, Viéitez I, Vázquez-Friol MDC, Torres-Beceiro I, Pérez-Gómez A, Gallego-García P, Estévez-Gómez N, De Chiara L, Poveda E, Posada D, Llibre JM. Álvarez H, et al. Microorganisms. 2022 Jan 11;10(1):143. doi: 10.3390/microorganisms10010143. Microorganisms. 2022. PMID: 35056592 Free PMC article.
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
Reverté L, Yeregui E, Olona M, Gutiérrez-Valencia A, Buzón MJ, Martí A, Gómez-Bertomeu F, Auguet T, López-Cortés LF, Burgos J, Benavent-Bofill C, Boqué C, García-Pardo G, Ruiz-Mateos E, Mestre MT, Vidal F, Viladés C, Peraire J, Rull A; COVIDOMICS Study Group. Reverté L, et al. Clin Transl Med. 2022 Jan;12(1):e704. doi: 10.1002/ctm2.704. Clin Transl Med. 2022. PMID: 35075803 Free PMC article. No abstract available.
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response.
Pérez-Gómez A, Gasca-Capote C, Vitallé J, Ostos FJ, Serna-Gallego A, Trujillo-Rodríguez M, Muñoz-Muela E, Giráldez-Pérez T, Praena-Segovia J, Navarro-Amuedo MD, Paniagua-García M, García-Gutiérrez M, Aguilar-Guisado M, Rivas-Jeremías I, Jiménez-León MR, Bachiller S, Fernández-Villar A, Pérez-González A, Gutiérrez-Valencia A, Rafii-El-Idrissi Benhnia M, Weiskopf D, Sette A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 and COHVID-GS Working Teams. Pérez-Gómez A, et al. Clin Transl Med. 2022 Apr;12(4):e802. doi: 10.1002/ctm2.802. Clin Transl Med. 2022. PMID: 35415890 Free PMC article.
132 results